Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology
NCT07303725 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2025-12-26
Summary
This is a pilot study to evaluate the feasibility, image quality, and procedural utility of a novel spectral CT technique using Canon Medical's 4D CT system during image-guided interventional oncology procedures
Conditions
- Liver Cancer (Primary and Metastatic)
- Renal Cancer
Sponsors & Collaborators
-
Canon Medical Systems, USA
collaborator INDUSTRY -
Palo Alto Veterans Institute for Research
lead OTHER
Principal Investigators
-
Sirish Kishore, MD · VA Palo Alto Health Care System
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-02-01
- Primary Completion
- 2026-02-01
- Completion
- 2026-09-01
Countries
- United States
Study Locations
More Related Trials
-
PET/CT: Role in Detecting Unknown Primary Head and Neck Cancer
NCT00656760 ·Status: COMPLETED ·Phase: NA
-
PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer
NCT02088775 ·Status: COMPLETED ·Phase: NA
-
68Ga-HA-DOTATATE PET/CT in Adults With Neuroendocrine Tumors
NCT05673031 ·Status: RECRUITING
-
68Ga-BNU-PSMA PET/CT in Patients With Various Types of Cancer
NCT04525612 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
A Pilot Study of Intraoperative Gamma Camera Imaging During Sentinel Node Biopsy for Melanoma
NCT00912730 ·Status: COMPLETED
-
MPDL3280A-imaging-IST-UMCG
NCT02453984 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
18F-LN1 PET/CT in Urothelial Carcinomas
NCT06120413 ·Status: RECRUITING
-
PixelShine vs. Iterative Reconstruction (IR) Processing of CT Images
NCT03033615 ·Status: UNKNOWN ·Phase: NA
-
Multi-Tracer PET Prediction and Assessment of Response to Gemcitabine in Pancreatic Cancer Patients
NCT02245217 ·Status: COMPLETED ·Phase: NA
-
CD70-targeted immunoPET Imaging of Kidney Cancer
NCT06680089 ·Status: RECRUITING ·Phase: PHASE2
-
PET / CT Imaging and Safety in Patients With Lymphoma Treated With CD19 Car-t Cells
NCT05176275 ·Status: UNKNOWN ·Phase: NA
-
Diagnosis of Renal Cell Carcinoma on 68Ga-PSMA PET-CT and Radioligand Therapy With 177Lu-EB-PSMA-617
NCT05170555 ·Status: UNKNOWN ·Phase: NA
-
PET/CT-Assessment of Liver Tumor Ablation
NCT02018107 ·Status: COMPLETED ·Phase: NA
-
PET Imaging of Cancer Patients Using 68Ga-DOTA-Siglec-9
NCT05212103 ·Status: ENROLLING_BY_INVITATION
-
IMaging Pilot Study of the αvβ6 Integrin Radiotracer [18F]-A20FMDV2 in PAtients With Solid Cancer Types
NCT04285996 ·Status: COMPLETED ·Phase: NA
-
FLT-PET/DW-MRI for Detection of Brain Metastases and Early Therapy Evaluation in Patients With Small Cell Lung Cancer
NCT02995902 ·Status: COMPLETED ·Phase: NA
-
Image and Dosimetry Related Research of Department of Medical Physics, Cross Cancer Institute
NCT00314470 ·Status: COMPLETED
-
Dual-Tracer Theranostic PET
NCT05680675 ·Status: COMPLETED ·Phase: NA
-
Combined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning Alone
NCT00351728 ·Status: COMPLETED
-
68Ga-DOTA-F2 PET/CT in Patients With Various Types of Cancer
NCT05637034 ·Status: UNKNOWN ·Phase: NA
-
A Pilot Study of [Ga-68]PSMA PET/MRI for the Assessment of PSMA-positive Tumors
NCT02978586 ·Status: COMPLETED
-
Renal Tumour Imaging Using MRI
NCT07173140 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Hyperpolarized 13C Pyruvate MRI Scan in Predicting Tumor Aggressiveness in Patients With Renal Tumors
NCT04258462 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Clinical Translation of a Novel Albumin-Binding PET Radiotracer 68Ga-NEB
NCT02496013 ·Status: UNKNOWN ·Phase: PHASE1
-
Comparative Analysis of SUV Measurements Using Different Correction Methods in Oncological PET/CT Imaging.
NCT07306975 ·Status: NOT_YET_RECRUITING